A detailed history of Profund Advisors LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 28,436 shares of CCCC stock, worth $115,450. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,436
Previous 34,149 16.73%
Holding current value
$115,450
Previous $157,000 3.18%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.43 - $7.38 $25,308 - $42,161
-5,713 Reduced 16.73%
28,436 $162,000
Q2 2024

Aug 13, 2024

SELL
$4.05 - $8.1 $373,009 - $746,018
-92,101 Reduced 72.95%
34,149 $157,000
Q1 2024

May 08, 2024

BUY
$5.3 - $11.0 $669,125 - $1.39 Million
126,250 New
126,250 $1.03 Million

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $199M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.